Bitte aktivieren Sie Javascript um alle Funktionen nutzen zu können und ihre Nutzererfahrung zu verbessern.
EHC 2022
Programm
Poster
Personen
Suche
EN
Alle Personen
Krisztian Nagy
Sortiert nach Typ
Datum
Vortrag
09.12.2022
15:35
–
15:40
3 Min.
2 Min.
ePoster
P103
Atogepant for the preventive treatment of chronic migraine: results from the PROGRESS phase 3 trial
Migraine
09.12.2022
15:45
–
15:50
3 Min.
2 Min.
ePoster
P141
Safety and tolerability of atogepant: a post hoc analysis of pooled data from four clinical trials
Migraine
09.12.2022
15:50
–
15:55
3 Min.
2 Min.
ePoster
P142
Effect of atogepant on Migraine-Specific Quality of Life Questionnaire and Headache Impact Test-6 in a 12-week, double-blind, randomized, phase 3 (PROGRESS) trial for preventive treatment of chronic migraine (CM)
Migraine
09.12.2022
16:40
–
16:45
3 Min.
2 Min.
ePoster
P117
Treatment Responder Rates of Oral Atogepant for the Preventive Treatment of Chronic Migraine: Results From the PROGRESS Trial
Migraine
Weitere Beteiligungen
09.12.2022
15:35
–
15:40
3 Min.
2 Min.
ePoster
P103
Atogepant for the preventive treatment of chronic migraine: results from the PROGRESS phase 3 trial
Migraine
09.12.2022
15:45
–
15:50
3 Min.
2 Min.
ePoster
P141
Safety and tolerability of atogepant: a post hoc analysis of pooled data from four clinical trials
Migraine
09.12.2022
15:50
–
15:55
3 Min.
2 Min.
ePoster
P142
Effect of atogepant on Migraine-Specific Quality of Life Questionnaire and Headache Impact Test-6 in a 12-week, double-blind, randomized, phase 3 (PROGRESS) trial for preventive treatment of chronic migraine (CM)
Migraine
09.12.2022
16:15
–
16:20
3 Min.
2 Min.
ePoster
P129
Atogepant for the Preventive Treatment of Chronic Migraine in Europe: Results From the PROGRESS Study
Migraine
09.12.2022
16:40
–
16:45
3 Min.
2 Min.
ePoster
P117
Treatment Responder Rates of Oral Atogepant for the Preventive Treatment of Chronic Migraine: Results From the PROGRESS Trial
Migraine
© Conventus Congressmanagement & Marketing GmbH
Impressum
Datenschutz